Cliff Asness's ANAB Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 32,467 shares of AnaptysBio, Inc. (ANAB) worth $1.8 M, representing 0.00% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ANAB, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2020, adding 60,068 shares. Largest reduction occurred in Q2 2022, reducing 38,833 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's AnaptysBio (ANAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly AnaptysBio (ANAB) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +6,158 | Add 23.41% | 32,467 | $55.46 |
| Q4 2025 | +135 | Add 0.52% | 26,309 | $48.48 |
| Q3 2025 | -1,548 | Reduce 5.58% | 26,174 | $30.62 |
| Q2 2025 | -2,289 | Reduce 7.63% | 27,722 | $22.20 |
| Q1 2025 | +18,165 | Add 153.34% | 30,011 | $18.59 |
| Q4 2024 | -36,746 | Reduce 75.62% | 11,846 | $13.24 |
| Q3 2024 | +48,592 | New Buy | 48,592 | $33.50 |
| Q2 2024 | -24,328 | Sold Out | 0 | $0.00 |
| Q1 2024 | +7,646 | Add 45.83% | 24,328 | $22.52 |
| Q4 2023 | +16,682 | New Buy | 16,682 | $21.42 |
| Q2 2022 | -38,833 | Sold Out | 0 | $0.00 |
| Q1 2022 | -169 | Reduce 0.43% | 38,833 | $24.75 |
| Q4 2021 | +12,657 | Add 48.04% | 39,002 | $34.74 |
| Q3 2021 | +11,712 | Add 80.04% | 26,345 | $27.10 |
| Q2 2021 | -8,541 | Reduce 36.86% | 14,633 | $25.90 |
| Q1 2021 | -36,894 | Reduce 61.42% | 23,174 | $21.53 |
| Q4 2020 | +60,068 | New Buy | 60,068 | $21.49 |
| Q1 2019 | -4,442 | Sold Out | 0 | $0.00 |
| Q4 2018 | -8,045 | Reduce 64.43% | 4,442 | $63.71 |
| Q3 2018 | -20,938 | Reduce 62.64% | 12,487 | $99.78 |
| Q2 2018 | +16,185 | Add 93.88% | 33,425 | $71.05 |
| Q1 2018 | +17,240 | New Buy | 17,240 | $104.06 |
Cliff Asness's AnaptysBio Investment FAQs
Cliff Asness first purchased AnaptysBio, Inc. (ANAB) in Q1 2018, acquiring 17,240 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held AnaptysBio, Inc. (ANAB) for 22 quarters since Q1 2018.
Cliff Asness's largest addition to AnaptysBio, Inc. (ANAB) was in Q4 2020, adding 60,068 shares worth $1.29 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 32,467 shares of AnaptysBio, Inc. (ANAB), valued at approximately $1.8 M.
As of the Q1 2026 filing, AnaptysBio, Inc. (ANAB) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in AnaptysBio, Inc. (ANAB) was 60,068 shares, as reported at the end of Q4 2020.